Scientists are rapidly examining retatrutide, a innovative treatment created by Eli Lilly, as a potential breakthrough in weight management. Unlike many previous approaches, retatrutide is a dual -action agonist targeting simultaneously GLP-1 and GIP, substances that influence satiety and blood … Read More